Twaro and all,
You are absolutely correct Twaro in that the e-mail discussion I had with Maureen from OHSU did not in any fashion represent a delay in the start of trials. If by chance a delay would happen, it certainly isn't because of what she said. Jules stein came on board for both trials 18 days prior to OHSU. Jules Stein would have needed training meetings also with the same group that needs to go to OHSU. Thinking that both clinical trial sites would be in exactly the same stage of the process would be a mistake. If anything was to be recognized(as new) from e-mail exchange I had, I felt it was the fact that OHSU is seeking IRB approval and dealing with contract to become a trial site for dryAMD. That was my original question to her and was glad to hear the response. I followed up with questions about the recruitment for Stargardt and was not surprised at the stage they were in given they have only been approved and on clinicaltrials.gov for 10 days.
To grasp at any straws from that exchange is unwarranted,imo. There is much more to these trials than most think. I have not heard anything from Jules Stein or anyone else to indicate a problem or delay, fwiw.